Global Rheumatology Drugs Market Research Report 2024

Report ID: 1898917 | Published Date: Jan 2025 | No. of Page: 92 | Base Year: 2024 | Rating: 3.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Rheumatology Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Disease Modifying Anti-rheumatic Drugs
        1.2.3 Nonsteroidal Anti-inflammatory Drugs
        1.2.4 Corticosteroids
        1.2.5 Uric Acid Drugs
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Rheumatology Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospital Pharmacy
        1.3.3 Retail Pharmacy
        1.3.4 Online Pharmacy
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Rheumatology Drugs Market Perspective (2017-2028)
    2.2 Rheumatology Drugs Growth Trends by Region
        2.2.1 Rheumatology Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Rheumatology Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Rheumatology Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Rheumatology Drugs Market Dynamics
        2.3.1 Rheumatology Drugs Industry Trends
        2.3.2 Rheumatology Drugs Market Drivers
        2.3.3 Rheumatology Drugs Market Challenges
        2.3.4 Rheumatology Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Rheumatology Drugs Players by Revenue
        3.1.1 Global Top Rheumatology Drugs Players by Revenue (2017-2022)
        3.1.2 Global Rheumatology Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Rheumatology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Rheumatology Drugs Revenue
    3.4 Global Rheumatology Drugs Market Concentration Ratio
        3.4.1 Global Rheumatology Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Rheumatology Drugs Revenue in 2021
    3.5 Rheumatology Drugs Key Players Head office and Area Served
    3.6 Key Players Rheumatology Drugs Product Solution and Service
    3.7 Date of Enter into Rheumatology Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Rheumatology Drugs Breakdown Data by Type
    4.1 Global Rheumatology Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028)
5 Rheumatology Drugs Breakdown Data by Application
    5.1 Global Rheumatology Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Rheumatology Drugs Market Size (2017-2028)
    6.2 North America Rheumatology Drugs Market Size by Country (2017-2022)
    6.3 North America Rheumatology Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Rheumatology Drugs Market Size (2017-2028)
    7.2 Europe Rheumatology Drugs Market Size by Country (2017-2022)
    7.3 Europe Rheumatology Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Rheumatology Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Rheumatology Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Rheumatology Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Rheumatology Drugs Market Size (2017-2028)
    9.2 Latin America Rheumatology Drugs Market Size by Country (2017-2022)
    9.3 Latin America Rheumatology Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Rheumatology Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Rheumatology Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Rheumatology Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Takeda Pharmaceutical
        11.1.1 Takeda Pharmaceutical Company Detail
        11.1.2 Takeda Pharmaceutical Business Overview
        11.1.3 Takeda Pharmaceutical Rheumatology Drugs Introduction
        11.1.4 Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2017-2022)
        11.1.5 Takeda Pharmaceutical Recent Development
    11.2 Sanofi
        11.2.1 Sanofi Company Detail
        11.2.2 Sanofi Business Overview
        11.2.3 Sanofi Rheumatology Drugs Introduction
        11.2.4 Sanofi Revenue in Rheumatology Drugs Business (2017-2022)
        11.2.5 Sanofi Recent Development
    11.3 Genentech
        11.3.1 Genentech Company Detail
        11.3.2 Genentech Business Overview
        11.3.3 Genentech Rheumatology Drugs Introduction
        11.3.4 Genentech Revenue in Rheumatology Drugs Business (2017-2022)
        11.3.5 Genentech Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Rheumatology Drugs Introduction
        11.4.4 Novartis Revenue in Rheumatology Drugs Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Janssen Biotech
        11.5.1 Janssen Biotech Company Detail
        11.5.2 Janssen Biotech Business Overview
        11.5.3 Janssen Biotech Rheumatology Drugs Introduction
        11.5.4 Janssen Biotech Revenue in Rheumatology Drugs Business (2017-2022)
        11.5.5 Janssen Biotech Recent Development
    11.6 Amgen
        11.6.1 Amgen Company Detail
        11.6.2 Amgen Business Overview
        11.6.3 Amgen Rheumatology Drugs Introduction
        11.6.4 Amgen Revenue in Rheumatology Drugs Business (2017-2022)
        11.6.5 Amgen Recent Development
    11.7 AbbVie
        11.7.1 AbbVie Company Detail
        11.7.2 AbbVie Business Overview
        11.7.3 AbbVie Rheumatology Drugs Introduction
        11.7.4 AbbVie Revenue in Rheumatology Drugs Business (2017-2022)
        11.7.5 AbbVie Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Rheumatology Drugs Introduction
        11.8.4 Pfizer Revenue in Rheumatology Drugs Business (2017-2022)
        11.8.5 Pfizer Recent Development
    11.9 Bristol-Myers Squibb Company
        11.9.1 Bristol-Myers Squibb Company Company Detail
        11.9.2 Bristol-Myers Squibb Company Business Overview
        11.9.3 Bristol-Myers Squibb Company Rheumatology Drugs Introduction
        11.9.4 Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2017-2022)
        11.9.5 Bristol-Myers Squibb Company Recent Development
    11.10 Merck & Co.
        11.10.1 Merck & Co. Company Detail
        11.10.2 Merck & Co. Business Overview
        11.10.3 Merck & Co. Rheumatology Drugs Introduction
        11.10.4 Merck & Co. Revenue in Rheumatology Drugs Business (2017-2022)
        11.10.5 Merck & Co. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Rheumatology Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Disease Modifying Anti-rheumatic Drugs
    Table 3. Key Players of Nonsteroidal Anti-inflammatory Drugs
    Table 4. Key Players of Corticosteroids
    Table 5. Key Players of Uric Acid Drugs
    Table 6. Key Players of Others
    Table 7. Global Rheumatology Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Rheumatology Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Rheumatology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 10. Global Rheumatology Drugs Market Share by Region (2017-2022)
    Table 11. Global Rheumatology Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 12. Global Rheumatology Drugs Market Share by Region (2023-2028)
    Table 13. Rheumatology Drugs Market Trends
    Table 14. Rheumatology Drugs Market Drivers
    Table 15. Rheumatology Drugs Market Challenges
    Table 16. Rheumatology Drugs Market Restraints
    Table 17. Global Rheumatology Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 18. Global Rheumatology Drugs Market Share by Players (2017-2022)
    Table 19. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
    Table 20. Ranking of Global Top Rheumatology Drugs Companies by Revenue (US$ Million) in 2021
    Table 21. Global 5 Largest Players Market Share by Rheumatology Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Rheumatology Drugs Product Solution and Service
    Table 24. Date of Enter into Rheumatology Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Rheumatology Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 27. Global Rheumatology Drugs Revenue Market Share by Type (2017-2022)
    Table 28. Global Rheumatology Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 29. Global Rheumatology Drugs Revenue Market Share by Type (2023-2028)
    Table 30. Global Rheumatology Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 31. Global Rheumatology Drugs Revenue Market Share by Application (2017-2022)
    Table 32. Global Rheumatology Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 33. Global Rheumatology Drugs Revenue Market Share by Application (2023-2028)
    Table 34. North America Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 35. North America Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Europe Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 37. Europe Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Asia-Pacific Rheumatology Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 39. Asia-Pacific Rheumatology Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 40. Latin America Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Latin America Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Middle East & Africa Rheumatology Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Middle East & Africa Rheumatology Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Takeda Pharmaceutical Company Detail
    Table 45. Takeda Pharmaceutical Business Overview
    Table 46. Takeda Pharmaceutical Rheumatology Drugs Product
    Table 47. Takeda Pharmaceutical Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 48. Takeda Pharmaceutical Recent Development
    Table 49. Sanofi Company Detail
    Table 50. Sanofi Business Overview
    Table 51. Sanofi Rheumatology Drugs Product
    Table 52. Sanofi Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 53. Sanofi Recent Development
    Table 54. Genentech Company Detail
    Table 55. Genentech Business Overview
    Table 56. Genentech Rheumatology Drugs Product
    Table 57. Genentech Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 58. Genentech Recent Development
    Table 59. Novartis Company Detail
    Table 60. Novartis Business Overview
    Table 61. Novartis Rheumatology Drugs Product
    Table 62. Novartis Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 63. Novartis Recent Development
    Table 64. Janssen Biotech Company Detail
    Table 65. Janssen Biotech Business Overview
    Table 66. Janssen Biotech Rheumatology Drugs Product
    Table 67. Janssen Biotech Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 68. Janssen Biotech Recent Development
    Table 69. Amgen Company Detail
    Table 70. Amgen Business Overview
    Table 71. Amgen Rheumatology Drugs Product
    Table 72. Amgen Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 73. Amgen Recent Development
    Table 74. AbbVie Company Detail
    Table 75. AbbVie Business Overview
    Table 76. AbbVie Rheumatology Drugs Product
    Table 77. AbbVie Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 78. AbbVie Recent Development
    Table 79. Pfizer Company Detail
    Table 80. Pfizer Business Overview
    Table 81. Pfizer Rheumatology Drugs Product
    Table 82. Pfizer Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 83. Pfizer Recent Development
    Table 84. Bristol-Myers Squibb Company Company Detail
    Table 85. Bristol-Myers Squibb Company Business Overview
    Table 86. Bristol-Myers Squibb Company Rheumatology Drugs Product
    Table 87. Bristol-Myers Squibb Company Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 88. Bristol-Myers Squibb Company Recent Development
    Table 89. Merck & Co. Company Detail
    Table 90. Merck & Co. Business Overview
    Table 91. Merck & Co. Rheumatology Drugs Product
    Table 92. Merck & Co. Revenue in Rheumatology Drugs Business (2017-2022) & (US$ Million)
    Table 93. Merck & Co. Recent Development
    Table 94. Research Programs/Design for This Report
    Table 95. Key Data Information from Secondary Sources
    Table 96. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Rheumatology Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Disease Modifying Anti-rheumatic Drugs Features
    Figure 3. Nonsteroidal Anti-inflammatory Drugs Features
    Figure 4. Corticosteroids Features
    Figure 5. Uric Acid Drugs Features
    Figure 6. Others Features
    Figure 7. Global Rheumatology Drugs Market Share by Application in 2021 & 2028
    Figure 8. Hospital Pharmacy Case Studies
    Figure 9. Retail Pharmacy Case Studies
    Figure 10. Online Pharmacy Case Studies
    Figure 11. Rheumatology Drugs Report Years Considered
    Figure 12. Global Rheumatology Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Rheumatology Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Rheumatology Drugs Market Share by Region: 2021 VS 2028
    Figure 15. Global Rheumatology Drugs Market Share by Players in 2021
    Figure 16. Global Top Rheumatology Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rheumatology Drugs as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Rheumatology Drugs Revenue in 2021
    Figure 18. North America Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Rheumatology Drugs Market Share by Country (2017-2028)
    Figure 20. United States Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Rheumatology Drugs Market Share by Country (2017-2028)
    Figure 24. Germany Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Rheumatology Drugs Market Share by Region (2017-2028)
    Figure 32. China Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Rheumatology Drugs Market Share by Country (2017-2028)
    Figure 40. Mexico Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Rheumatology Drugs Market Share by Country (2017-2028)
    Figure 44. Turkey Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Rheumatology Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Takeda Pharmaceutical Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 47. Sanofi Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 48. Genentech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 50. Janssen Biotech Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 51. Amgen Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 52. AbbVie Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 53. Pfizer Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 54. Bristol-Myers Squibb Company Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 55. Merck & Co. Revenue Growth Rate in Rheumatology Drugs Business (2017-2022)
    Figure 56. Bottom-up and Top-down Approaches for This Report
    Figure 57. Data Triangulation
    Figure 58. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takeda Pharmaceutical
Sanofi
Genentech
Novartis
Janssen Biotech
Amgen
AbbVie
Pfizer
Bristol-Myers Squibb Company
Merck & Co.
Frequently Asked Questions
Rheumatology Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Rheumatology Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Rheumatology Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Rolled Glass

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More